| The effects of inhaled nitric oxide after lung transplantation. | |
| | |
MedLine Citation:
|
PMID: 20395898 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Primary graft failure (PGF) is one of the major complications that occurs immediately following lung transplantation and greatly contributes to increased morbidity and mortality. The incidence of PGF is correlated with a marked decline in endogenous nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) levels. Therefore, the administration of NO during lung transplantation has been proposed as a possible therapeutic treatment to prevent or attenuate PGF pathogenesis. Despite the initial positive results of experimental and uncontrolled clinical trials, recent randomized clinical trials do not support the prophylactic administration of inhaled nitric oxide (iNO) for the prevention of PGF following lung transplantation under the conditions tested. Nonetheless, there is evidence that iNO administration during PGF can improve oxygenation and reduce pulmonary hypertension without altering systemic vascular resistance. This suggests that iNO may prevent the need for extracorporeal membrane oxygenation (ECMO) during the hypoxic phase of PGF. During the intraoperative phase of transplantation, one-lung ventilation (OLV) and pulmonary artery clamping usually increase PVR, causing decreased right ventricular function and hemodynamic instability. The administration of iNO during these lung transplant procedures could decrease right ventricular dysfunction by reducing PVR and help to avoid the use of cardiopulmonary bypass. |
| | |
Authors:
|
D Pasero; E L Martin; A Davi; L Mascia; M Rinaldi; V M Ranieri |
Related Documents
:
|
15184198 - Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung tra... 7515778 - Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients wit... 16215158 - Current nutrition practices in adult lung transplantation. 15312828 - Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury... 9884248 - A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after... 7943168 - Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Minerva anestesiologica Volume: 76 ISSN: 1827-1596 ISO Abbreviation: Minerva Anestesiol Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-16 Completed Date: 2010-07-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375272 Medline TA: Minerva Anestesiol Country: Italy |
Other Details:
|
Languages: eng Pagination: 353-61 Citation Subset: IM |
Affiliation:
|
Department of Anesthesia and Critical Care Medicine, University of Turin, S. Giovanni Battista Hospital, Turin, Italy. dpasero@molinette.piemonte.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bronchodilator Agents
/
administration & dosage,
therapeutic use* Humans Lung Transplantation / physiology* Nitric Oxide / administration & dosage, therapeutic use* Pulmonary Circulation Reperfusion Injury / prevention & control Respiration, Artificial Vasodilator Agents / administration & dosage, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Bronchodilator Agents; 0/Vasodilator Agents; 10102-43-9/Nitric Oxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: NAVA ventilation.
Next Document: Post-cardiac arrest syndrome.